Sandwich, United Kingdom

Michael John Humphrey


 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 131(Granted Patents)


Location History:

  • County of Kent, GB (2005)
  • Sandwich, GB (1989 - 2007)

Company Filing History:


Years Active: 1989-2007

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael John Humphrey: Innovator in Pharmaceutical Formulations

Introduction

Michael John Humphrey is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on developing innovative formulations that enhance the efficacy of medications.

Latest Patents

Among his latest patents, one notable invention is a controlled-release pharmaceutical formulation for oral administration. This formulation includes 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline, or a pharmaceutically acceptable salt thereof. The formulation is designed to release at least 50% by weight of the active ingredient after 6 hours, making it suitable for the treatment of benign prostatic hyperplasia (BPH). Another significant patent involves therapeutic compositions comprising a mixture of amlodipine enantiomers, which possess both anti-hypertensive and cardiovascular properties.

Career Highlights

Michael John Humphrey is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of advanced therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, Humphrey has collaborated with esteemed colleagues, including Thomas Francis Dolan and Donald John Nichols. These collaborations have further enriched his research and innovation in the pharmaceutical sector.

Conclusion

Michael John Humphrey's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents reflect a deep understanding of drug delivery systems and their impact on patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…